Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Jiangzhuo Decoction granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Beijing Pinggu District Hospital of Traditional Chinese Medicine. It is specifically designed to treat asymptomatic hyperuricemia, particularly in patients presenting with the TCM syndrome of spleen deficiency and turbid obstruction. The decoction aims to "strengthen the spleen" (Jianpi) and "resolve turbidity" (Jiangzhuo), which in a modern clinical context translates to the reduction of serum uric acid levels. It is currently being evaluated in a prospective, randomized, double-blind, placebo-controlled clinical trial to assess its efficacy and safety in adult patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Jiangzhuo Decoction granules.